Lpwm LLC Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Lpwm LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 80.8% during the 4th quarter, Holdings Channel reports. The institutional investor owned 866 shares of the healthcare conglomerate’s stock after acquiring an additional 387 shares during the period. Lpwm LLC’s holdings in UnitedHealth Group were worth $438,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Tlwm increased its stake in UnitedHealth Group by 4.0% during the fourth quarter. Tlwm now owns 2,708 shares of the healthcare conglomerate’s stock worth $1,370,000 after purchasing an additional 105 shares during the period. Tuttle Capital Management LLC increased its stake in UnitedHealth Group by 34.1% during the fourth quarter. Tuttle Capital Management LLC now owns 629 shares of the healthcare conglomerate’s stock worth $318,000 after purchasing an additional 160 shares during the period. Rosenberg Matthew Hamilton grew its position in shares of UnitedHealth Group by 50.3% during the fourth quarter. Rosenberg Matthew Hamilton now owns 1,320 shares of the healthcare conglomerate’s stock worth $668,000 after buying an additional 442 shares in the last quarter. Signal Advisors Wealth LLC grew its position in shares of UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after buying an additional 1,051 shares in the last quarter. Finally, Ayrshire Capital Management LLC grew its position in shares of UnitedHealth Group by 2.2% during the fourth quarter. Ayrshire Capital Management LLC now owns 11,232 shares of the healthcare conglomerate’s stock worth $5,682,000 after buying an additional 244 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. UBS Group lowered their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Morgan Stanley lowered their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Truist Financial lowered their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. One analyst has rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and an average target price of $626.79.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $543.76 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The business has a 50 day simple moving average of $554.45 and a 200-day simple moving average of $563.12. The stock has a market capitalization of $500.41 billion, a PE ratio of 35.42, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the prior year, the business earned $6.56 earnings per share. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.54%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.